首页> 外国专利> INSPECTION METHOD FOR PREDICTING EFFICACY OF TREATING PATIENTS WITH LUNG CANCER, AND SCREENING METHOD FOR LUNG CANCER THERAPEUTIC AGENT

INSPECTION METHOD FOR PREDICTING EFFICACY OF TREATING PATIENTS WITH LUNG CANCER, AND SCREENING METHOD FOR LUNG CANCER THERAPEUTIC AGENT

机译:检验肺癌患者治疗效果的检查方法和肺癌治疗剂的筛查方法

摘要

PROBLEM TO BE SOLVED: To provide an inspection method for predicting efficacy of treating patients with lung cancer, particularly NSCLC patients with EGFR-TKI resistance, and to provide a screening method for a lung cancer therapeutic agent.;SOLUTION: It is found that when BIM in the sample derived from NSCLC patients with EGFR-TKI resistance is a non-wild type, although a single administration of EGFR-TKI (epidermal growth factor receptor tyrosine kinase inhibitors) shows a low efficacy of treatment, a combined administration of EGFR-TKI with a histone deacetylation enzyme inhibitor, or docetaxel shows high efficacy of treatment, which results in completing the prediction inspection method and the screening method of the invention.;COPYRIGHT: (C)2014,JPO&INPIT
机译:解决的问题:提供一种检查方法,以预测治疗肺癌患者,尤其是EGFR-TKI耐药性的NSCLC患者的疗效,并提供一种肺癌治疗剂的筛选方法。 EGFR-TKI耐药的NSCLC患者样本中的BIM是非野生型,尽管单次使用EGFR-TKI(表皮生长因子受体酪氨酸激酶抑制剂)显示出低治疗效果,但联合使用EGFR-TKI含组蛋白脱乙酰基酶抑制剂或多西紫杉醇的TKI具有很高的治疗效果,从而完成了本发明的预测检查方法和筛选方法。;版权所有:(C)2014,JPO&INPIT

著录项

  • 公开/公告号JP2014168434A

    专利类型

  • 公开/公告日2014-09-18

    原文格式PDF

  • 申请/专利权人 KANAZAWA UNIV;

    申请/专利号JP20130042439

  • 申请日2013-03-04

  • 分类号C12Q1/68;C12Q1/04;

  • 国家 JP

  • 入库时间 2022-08-21 16:20:04

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号